Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
RILUZOL 50 mg/stuk
Hexal AG Industriestrasse 25 D-83607 HOLZKIRCHEN (DUITSLAND)
N07XX02
RILUZOL 50 mg/stuk
Filmomhulde tablet
CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341) ; CELLULOSE, MICROKRISTALLIJN (E 460) ; CROSCARMELLOSE NATRIUM (E 468) ; HYPROMELLOSE (E 464) ; MACROGOL 6000 ; MAGNESIUMSTEARAAT (E 470b) ; SILICIUMDIOXIDE (E 551) ; TITAANDIOXIDE (E 171),
Oraal gebruik
Riluzole
Hulpstoffen: CALCIUMWATERSTOFFOSFAAT 0-WATER (E 341); CELLULOSE, MICROKRISTALLIJN (E 460); CROSCARMELLOSE NATRIUM (E 468); HYPROMELLOSE (E 464); MACROGOL 6000; MAGNESIUMSTEARAAT (E 470b); SILICIUMDIOXIDE (E 551); TITAANDIOXIDE (E 171);
2011-01-26
Hexal AG Page 1/8 Riluzol Hexal 50 mg, filmomhulde tabletten RVG106639 V8 1.3.1.3 Bijsluiter Januari 2023 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT RILUZOL HEXAL ® 50 MG, FILMOMHULDE TABLETTEN riluzole READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor or pharmacist. − This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. − If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What [nationally completed name] is and what it is used for 2. What you need to know before you take [nationally completed name] 3. How to take [nationally completed name] 4. Possible side effects 5. How to store [nationally completed name] 6. Content of the pack and other information 1. WHAT [NATIONALLY COMPLETED NAME] IS AND WHAT IT IS USED FOR WHAT [NATIONALLY COMPLETED NAME] IS The active substance in [nationally completed name] is riluzole which acts on the nervous system. WHAT [NATIONALLY COMPLETED NAME] IS USED FOR Hexal AG Page 2/8 Riluzol Hexal 50 mg, filmomhulde tabletten RVG106639 V8 1.3.1.3 Bijsluiter Januari 2023 [nationally completed name] is used in patients with amyotrophic lateral sclerosis (ALS). ALS is a form of motor neurone disease where attacks of the nerve cells responsible for sending instructions to the muscles lead to weakness, muscle waste and paralysis. The destruction of nerve cells in motor neurone disease may be caused by too much glutamate (a chemical messenger) in the brain and spinal cord. [nationally completed name] stops the release of glutamate and this may help in preventing the nerve cells being damaged. Please consult your doctor for more information about ALS and the reason why this medicine has been pr Lees het volledige document
Hexal AG Page 1/9 Riluzol Hexal 50 mg, filmomhulde tabletten RVG 106639 V6 1.3.1.1 Samenvatting van de Productkenmerken Januari 2023 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Riluzol Hexal 50 mg, filmomhulde tabletten 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 50 mg of riluzole. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. White to off-white, film-coated, capsule shaped tablet with ‘RLZ’ debossed on one side and plain on other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS [Nationally completed name] is indicated to extend life or the time to mechanical ventilation for patients with amyotrophic lateral sclerosis (ALS). Clinical trials have demonstrated that [Nationally completed name] extends survival for patients with ALS (see section 5.1). Survival was defined as patients who were alive, not intubated for mechanical ventilation and tracheotomy-free. There is no evidence that [Nationally completed name] exerts a therapeutic effect on motor function, lung function, fasciculations, muscle strength and motor symptoms. [Nationally completed name] has not been shown to be effective in the late stages of ALS. Safety and efficacy of [Nationally completed name] has only been studied in ALS. Therefore, [Nationally completed name] should not be used in patients with any other form of motor neurone disease. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Treatment with [Nationally completed name] should only be initiated by specialist physicians with experience in the management of motor neurone diseases. The recommended daily dose in adults or elderly is 100 mg (50 mg every 12 hours). No significant increased benefit can be expected from higher daily doses. SPECIAL POPULATIONS Hexal AG Page 2/9 Riluzol Hexal 50 mg, filmomhulde tabletten RVG 106639 V6 1.3.1.1 Samenvatting van de Productkenmerken Januari 2023 Paediatric population: [Nationally completed name] is not recommended for use in children, due to a lack Lees het volledige document